Dr. Nelson joined Deerfield in 2019 as Vice President of Genetics and Genomics at Deerfield Discovery and Development, LLC. Dr. Nelson joined Deerfield from GlaxoSmithKline, where he spent almost 15 years and was most recently the Head of Genetics. Prior to GlaxoSmithKline, Dr. Nelson was the Director of Biostatistics at Sequenom. He began his career as an information scientist at Esperion Therapeutics. Dr. Nelson was an Adjunct Associate Professor of Biostatistics at the University of North Carolina from 2010 to 2016. He holds a Ph.D. in Human Genetics and M.A. in Statistics from the University of Michigan, and obtained his B.S. in Molecular Biology from Brigham Young University.
The vast majority of available genomic data is from participants that are of white, European ancestry, therefore representing a fraction of the world’s population only. Continued disproportionate advances in genome sciences will exacerbate global healthcare disparities in several ways. This session will address how coordinated, multi-sector solutions could address and preempt such disparities to ensure the promise of precision medicines is realized globally.